Anastrozole

Anastrozole is used to treat breast cancer in women who have already gone through menopause. It is specifically used for hormone-receptor-positive breast cancer, which is a type of cancer that grows in response to the hormone estrogen.

Common situations where anastrozole is prescribed include:

• Early-stage breast cancer: It is often used as an additional treatment after surgery or radiation to reduce the risk of the cancer returning.
• Advanced breast cancer: It is used to treat cancer that has spread locally within the breast or to other parts of the body (metastatic cancer).
• After other hormone therapies: It may be prescribed if the cancer has continued to grow or spread after treatment with other medications, such as tamoxifen.

This medication is not used in women who are still of childbearing age or who have not yet completed menopause.

How Anastrozole Works

Anastrozole belongs to a class of medications known as nonsteroidal aromatase inhibitors. It is primarily used to treat breast cancer in women who have already gone through menopause.

Many types of breast cancer are hormone-receptor-positive, meaning they use estrogen as fuel to grow and spread. In women who have completed menopause, the ovaries no longer produce estrogen. Instead, the body produces estrogen by converting other hormones, called androgens, into estrogen using an enzyme called aromatase.

Anastrozole works by attaching to the aromatase enzyme and blocking it from performing this conversion. By inhibiting this process, the medication significantly reduces the total amount of estrogen circulating in the body. This helps to:

• Deprive hormone-sensitive cancer cells of the estrogen they need to multiply.
• Slow down or stop the growth of existing tumors.
• Reduce the risk of the cancer returning after other treatments, such as surgery or radiation.

Because anastrozole targets the aromatase enzyme rather than the ovaries, it is generally only effective for women whose ovaries are no longer producing estrogen.

Common Side Effects

Many people taking anastrozole experience mild to moderate side effects. These may include:

• Hot flashes and sweating
• Joint pain, stiffness, or bone pain
• Weakness or lack of energy
• Nausea and vomiting
• Headache
• Sore throat or cough
• Back pain
• Swelling in the arms, legs, or feet
• Difficulty sleeping (insomnia)
• Mood changes or depression
• Thinning hair
• Skin rash

Serious Side Effects

While less common, some side effects require immediate medical attention. Contact a healthcare provider right away if you experience:

• Chest pain or pressure
• Shortness of breath
• Sudden numbness or weakness, especially on one side of the body
• Signs of an allergic reaction, such as hives, swelling of the face, lips, or throat, and difficulty breathing
• Severe skin reactions, including blistering or peeling
• Yellowing of the eyes or skin (jaundice) or dark urine
• Pain in the upper right part of the stomach
• Blurred vision or eye pain
• Bone fractures or severe bone pain

Anastrozole can decrease bone mineral density, which may increase the risk of developing osteoporosis or experiencing bone fractures. Healthcare providers may monitor bone health or recommend supplements during treatment.

Pregnancy and Reproductive Health

Anastrozole is contraindicated for use during pregnancy because it can cause harm to a developing fetus. It is intended for use only in women who have reached menopause. Women who are of reproductive potential should use effective birth control during treatment and for at least three weeks after the final dose.

Bone Density and Fractures

This medication works by lowering estrogen levels, which can lead to a reduction in bone mineral density. This loss of bone strength increases the risk of osteoporosis and bone fractures, particularly in the spine, hip, and wrist. Healthcare providers may recommend bone density screenings before and during treatment.

Heart Health

In women with pre-existing ischemic heart disease, such as a history of narrowed heart arteries or chest pain, there may be an increased risk of cardiovascular complications while taking anastrozole. It is important to discuss any history of heart problems or high blood pressure with a healthcare provider.

Cholesterol and Liver Monitoring

• Cholesterol: Anastrozole may lead to elevated blood cholesterol levels. Periodic monitoring through blood tests is often recommended.
• Liver Disease: The medication should be used with caution in patients with moderate to severe liver impairment, as the liver is responsible for processing the drug.

Hypersensitivity Reactions

Serious allergic reactions have been reported, including angioedema (swelling of the face, lips, or throat) and anaphylaxis. Immediate medical attention is necessary if symptoms such as difficulty breathing, hives, or severe skin rashes occur.

Pregnancy

Anastrozole is primarily intended for use in women who have already completed menopause. It should not be used during pregnancy, as it may cause birth defects or pregnancy loss. Healthcare providers typically require a pregnancy test to confirm a patient is not pregnant before starting this medication. Individuals who are able to become pregnant should use effective birth control during treatment and for at least three weeks after the final dose.

Breastfeeding

It is not known whether anastrozole passes into human breast milk. Because of the potential for serious side effects in a nursing child, breastfeeding is not recommended during treatment and for at least two weeks following the last dose. Patients should discuss their specific situation and feeding options with a healthcare provider.

Dosage Forms

Anastrozole is available in the following form:

• Oral tablet

This medication is taken by mouth and is not available in other formulations such as liquids or injections.

FDA Approval and Indications

Anastrozole is approved by the U.S. Food and Drug Administration (FDA) for several specific uses in postmenopausal women with breast cancer. These indications include:

• Adjuvant Treatment: It is used as an additional treatment for early-stage hormone receptor-positive breast cancer to help prevent the cancer from returning.
• First-Line Treatment: It is approved for the initial treatment of hormone receptor-positive or hormone receptor-unknown locally advanced or metastatic breast cancer.
• Second-Line Treatment: It is used to treat advanced breast cancer that has continued to grow or spread after treatment with tamoxifen.

Regulatory Requirements and Biomarkers

The FDA includes pharmacogenomic information in the labeling for anastrozole. Its use is specifically tied to the presence of estrogen or progesterone receptors in the tumor. Clinical evidence indicates that the drug is most effective in patients whose breast cancer is hormone receptor-positive.

Anastrozole is not approved for use in premenopausal women or in pediatric patients. There are currently no Boxed Warnings or Risk Evaluation and Mitigation Strategies (REMS) associated with this medication. It remains a prescription-only drug that requires ongoing medical supervision to monitor for potential side effects such as changes in bone mineral density or cholesterol levels.

Weight Changes and Anastrozole

Anastrozole is frequently associated with weight gain. As an aromatase inhibitor, it works by significantly reducing the amount of estrogen in the body. These hormonal shifts can affect metabolism and how the body processes and stores fat, often leading to an increase in weight.

Common observations regarding weight while taking this medication include:

• A gradual increase in body weight during the course of treatment.
• Potential fluid retention or swelling in the extremities, which may reflect as weight gain on a scale.

Patients are encouraged to maintain a healthy diet and engage in regular physical activity to help manage weight changes. If weight gain becomes a concern or is accompanied by significant swelling, it should be discussed with a healthcare professional to rule out other causes and develop a management plan.